Skip to content Skip to footer

Endocrinology

Creating Better Possibilities in
Hormonal Health

The research below reflects our commitment to advancing treatments for conditions that require ongoing care, generating evidence that continues to shape the future of endocrine medicine.

Active Studies
0
Recruiting
0
Therapeutic Areas
0
Past Studies

Contributing to the Next Generation of Endocrine Therapies

Endocrine disorders often extend far beyond the symptoms themselves, shaping daily routines, long-term health decisions, and overall quality of life. At Zillan Clinical Research, we have had the privilege of working alongside individuals who chose to participate in endocrinology studies focused on conditions such as diabetes and other hormonal disorders. Each completed trial has contributed meaningful insights to the scientific community, helping advance our understanding of endocrine disease and bringing us closer to more effective treatment options for future patients.

Completed Studies

At Zillan Clinical Research, the studies listed below were completed in collaboration with leading pharmaceutical and biotechnology partners, generating valuable data that supports ongoing advancements in endocrine care and the development of improved future treatment options for patients with hormonal disorders.

ENDOCRINOLOGY

About Type 1 Diabetes Clinical Trials

Type 1 diabetes affects millions of people worldwide and requires lifelong insulin replacement and careful daily disease management from the time of diagnosis. To advance research in this area, Zillan Clinical Research conducted a Phase 1b/2a, randomized, double-blind study evaluating CNP-103 in adolescents and adults aged 12–35 with recently diagnosed Stage 3 Type 1 diabetes. The study assessed safety, tolerability, and early clinical outcomes to support future treatment development in Type 1 diabetes.

Not Recruiting

Current Status

Type 1 Diabetes

Condition

Endocrinology

Lorem Ipsum is simply dummy text.

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library, took a 1914 Cicero translation and scrambled it.

Not Recruiting

Current Status

Lorem Ipsum

Condition